Bacterioboat – a novel concurrent of CD-enabled drug delivery
In a recent study published in Science Advances, Diptiman Choudhury, a biochemist at the Thapar Institute of Engineering and Technology,
Tag: Cancer therapy
Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy
In the past few years, drug delivery systems have been used extensively to improve solubility, stability, and pharmacokinetics of chemotherapeutic
A different approach to immunochemotherapy for colon cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU
Immune system deficiencies are crucial in the progression of cancer, predominantly because immune cells are not stimulated by cytokines to
Carrier in carrier: Catanionic vesicles based on amphiphilic cyclodextrins complexed with DNA as nanocarriers of doxorubicin
The aim of this study was to evaluate the interaction between catanionic vesicles based on amphiphilic cyclodextrins (ModCBHD) and DNA–Doxorubicin
Biophysical Studies and In Vitro Effects on Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes
Phytocannabinoids possess anticancer properties, as established in vitro and in vivo. However, they are characterized by high lipophilicity. To improve
Cancer-Related Intracellular Signalling Pathways Activated by Doxorubicin/Cyclodextrin-Graphene-Based Nanomaterials
In the last decade, nanotechnological progress has generated new opportunities to improve the safety and efficacy of conventional anticancer therapies.
When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications through Network Science and Text-Mining
This review of Rincón-López et al. (2021) was published in the special issue Pharmaceutical and Biomedical Applications of Cyclodextrins and
Folate-appended CDs in cancer therapy
The team of Motoyama in Kumamoto has recently published new results on folate-appended CDs in leukemia and ovarian cancer (1,2).
Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment
A novel folate receptor-targeted β-cyclodextrin drug delivery vehicle was constructed to improve the bioavailability, biosafety, and drug loading capacity of